Bristol Myers Squibb (NYSE: BMY) reported revenues of $11.2 billion for the third quarter of 2022, down 3% from the same period a year ago.
Net earnings attributable to BMS were $1.60 billion, or $0.75 per share, compared to $1.54 billion, or $0.69 per share, last year. Adjusted EPS rose 3% to $1.99.
For the full year of 2022, the company expects adjusted EPS of $7.44-7.74.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Ulta Beauty (ULTA) Earnings: 1Q24 Key Numbers
Ulta Beauty, Inc. (NASDAQ: ULTA) reported net sales of $2.7 billion for the first quarter of 2024, up 3.5% year-over-year, driven by higher comparable sales, new store contribution, and growth
Costco reports stronger-than-expected Q3 earnings; revenue up 9%
Costco Wholesale Corporation (NASDAQ: COST), which operates a chain of membership warehouses, Thursday reported higher earnings and sales for the third quarter. Earnings also came in above estimates. Q3 revenues
Key takeaways from Hormel Foods’ (HRL) Q2 2024 earnings report
Shares of Hormel Foods Corporation (NYSE: HRL) plunged 8% on Thursday after the company delivered mixed results for the second quarter of 2024. Earnings beat expectations while revenues missed the